NO20031045L - New polymorphic form of 17- <beta> - (N-tert-butylcarbamoyl) -4-aza-5- <alfa> -ANDROST-1-en-3-one and a process for preparing the same - Google Patents

New polymorphic form of 17- <beta> - (N-tert-butylcarbamoyl) -4-aza-5- <alfa> -ANDROST-1-en-3-one and a process for preparing the same

Info

Publication number
NO20031045L
NO20031045L NO20031045A NO20031045A NO20031045L NO 20031045 L NO20031045 L NO 20031045L NO 20031045 A NO20031045 A NO 20031045A NO 20031045 A NO20031045 A NO 20031045A NO 20031045 L NO20031045 L NO 20031045L
Authority
NO
Norway
Prior art keywords
androst
butylcarbamoyl
alfa
aza
tert
Prior art date
Application number
NO20031045A
Other languages
Norwegian (no)
Other versions
NO20031045D0 (en
Inventor
Satyanarayana M Reddy
T S Rajan
Brahmeshwara M V N Rao
K Vyas
Vishnuvardhana S Reddy
Shashi K Rekha
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of NO20031045D0 publication Critical patent/NO20031045D0/en
Publication of NO20031045L publication Critical patent/NO20031045L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20031045A 2000-09-07 2003-03-06 New polymorphic form of 17- <beta> - (N-tert-butylcarbamoyl) -4-aza-5- <alfa> -ANDROST-1-en-3-one and a process for preparing the same NO20031045L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN737DE2000 2000-09-07
PCT/US2001/019546 WO2002020553A1 (en) 2000-09-07 2001-06-19 NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT

Publications (2)

Publication Number Publication Date
NO20031045D0 NO20031045D0 (en) 2003-03-06
NO20031045L true NO20031045L (en) 2003-04-29

Family

ID=11097081

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031045A NO20031045L (en) 2000-09-07 2003-03-06 New polymorphic form of 17- <beta> - (N-tert-butylcarbamoyl) -4-aza-5- <alfa> -ANDROST-1-en-3-one and a process for preparing the same

Country Status (12)

Country Link
EP (1) EP1322663A1 (en)
JP (1) JP2004508380A (en)
AU (1) AU6991101A (en)
BR (1) BR0113732A (en)
CA (1) CA2422159A1 (en)
HU (1) HUP0300937A3 (en)
IL (1) IL154785A0 (en)
NO (1) NO20031045L (en)
NZ (1) NZ525116A (en)
PL (1) PL361014A1 (en)
WO (1) WO2002020553A1 (en)
ZA (1) ZA200302554B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2206065B1 (en) * 2002-10-31 2005-08-16 Ragactives, S.L. PROCEDURE FOR OBTAINING THE POLYMORPHIC FORM I OF FINASTERIDA.
EP1651661B1 (en) * 2003-07-03 2008-08-27 Cipla Ltd. Process for the preparation of finasteride form i
CN1294913C (en) * 2004-12-23 2007-01-17 鲁南制药集团股份有限公司 Medication combination of containing finasteride and cyclodextrin or ramification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
US5021575A (en) * 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
US5091534A (en) * 1990-08-27 1992-02-25 Merck & Co., Inc. Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes

Also Published As

Publication number Publication date
BR0113732A (en) 2003-07-29
NZ525116A (en) 2004-11-26
CA2422159A1 (en) 2002-03-14
JP2004508380A (en) 2004-03-18
EP1322663A1 (en) 2003-07-02
ZA200302554B (en) 2004-02-19
PL361014A1 (en) 2004-09-20
HUP0300937A3 (en) 2007-10-29
IL154785A0 (en) 2003-10-31
NO20031045D0 (en) 2003-03-06
AU6991101A (en) 2002-03-22
HUP0300937A2 (en) 2007-02-28
WO2002020553A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
DE60000551D1 (en) Yellow recording liquid, manufacturing process and use
DK1180518T3 (en) 5-pyridyl-1,3-azole compounds, process for their preparation and use thereof
DK1036794T3 (en) 2-Aryl-8-oxodihydropurine derivatives, process for preparing the same, medical preparations containing the same and intermediates thereof
DE60042626D1 (en) Zipper
DK1157023T3 (en) C-21 modified epothilones
NO20022895L (en) Methods for the preparation of carotenoids and for the preparation of feed materials
DK1144386T3 (en) Polymorphic form of telmisartan, process for its preparation and use thereof for the manufacture of a drug
IS5715A (en) Method for the construction of 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
NO20012963L (en) Process for the preparation of 3-alkanoylindoles and 3-alkylindoles
DE60030831D1 (en) Zipper
DK1138677T3 (en) Process for the preparation of 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo [c, f] [1,2] -thiazepine and use in the synthesis of thianeptine
NO20031319D0 (en) Process for the preparation of N- (substituted phenyl) -3-alkyl, aryl and heteroaryl-sulfonyl-2-hydroxy-2-alkyl and haloalkylpropanamide compounds
DK1399424T3 (en) Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz [b, f] azepine-5-carboxamide and 10,11-dihydro-10-oxo-5H-dibenz [b, f] azepine-5 carboxamide
NO20025069D0 (en) New stable crystal of thiazolidinedione derivative and process for preparing the same
NO20001909D0 (en) Process and plant for the preparation of 1,2-dichloroethane
NO20031045L (en) New polymorphic form of 17- &lt;beta&gt; - (N-tert-butylcarbamoyl) -4-aza-5- &lt;alfa&gt; -ANDROST-1-en-3-one and a process for preparing the same
GB2359635B (en) Photographic element, compound, and process
DK1341758T3 (en) Coniosetin and its derivatives, process for the preparation and use of the same
NO20012099D0 (en) Process for the preparation of 4-arylpiperidine-3-carbinols and related compounds
NO20000965L (en) Process for the preparation of growth hormone-secreting compounds
NO20030515L (en) Process for the preparation of dinapsoline
ATE274683T1 (en) PYROMETALLURGIC REACTOR COOLING ELEMENT AND PRODUCTION THEREOF
NO20020328D0 (en) Process for the preparation of 4-cyano-2-aminomethylthiazole
HU9900123D0 (en) 1-isothiazolidinone derivatives of azetidine-2-one, processes for the preparation thereof and use thereof
DK1080076T3 (en) Improved process for the preparation of pharmaceutically valuable norbenzomorphan derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application